KevinMD January 21, 2025
Jennifer Bath, PhD

Across all industries, artificial intelligence is changing our approach to developing new products, including in the life sciences and drug development. While it may seem that an AI-derived treatment is far in the future, the science, biomathematics, and computational power needed to discover and test these compounds are advancing at a rapid pace. AI is the new, better way to more quickly and accurately identify the next big drug candidate.

How AI is speeding up drug development

Until recently, new drug candidates were almost discovered by accident, after researchers experimented in the lab with a hypothesis in mind, but one that needed to be tested with time-consuming trial and error. Traditionally, it takes 10 to 15 years on average to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology
The 3 most promising uses for GenAI in healthcare
OpenAI’s $40 Billion And Circle IPO: AI And Blockchain’s Revolution
The Flawed Assumption Behind AI Agents’ Decision-Making
Q&A: Researcher discusses agentic AI, expected to be the next trend in digital medicine
Generative AI Is A Crisis For Copyright Law

Share This Article